Skip to main content
Premium Trial:

Request an Annual Quote

Who Cares If They're Small? They're Sticky!

MIT, Harvard, and Massachusetts General Hospital have teamed up to commercialize a new diagnostic that uses magnetic nanoparticles to detect viruses and bacteria, reports MIT’s Technology Review. The company, T2 Biosystems, has developed particles that are coated with molecules like antibodies or DNA; when exposed to a magnetic field, the particles bind to their target and form clumps that can be easily visualized. The hope is that the particles will be able to identify viruses and infectious pathogens earlier, as well as help monitor cancer more easily.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.